← FDA Drug Approvals (Drugs@FDA)
DAPTOMYCIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2022-12-23
Drug application
- FDA Application #
ANDA216445- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DAPTOMYCIN
- Generic name
- DAPTOMYCIN
- Active ingredients
- DAPTOMYCIN
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- ASPIRO
- Manufacturer
- NorthStar RxLLC
- First approval
- 2022-12-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown